XIFIN, Inc.

XIFIN, Inc.

XIFIN, Inc.

Overview
Date Founded

1997

Headquarters

12225 EL CAMINO REAL, SAN DIEGO, CA, 92130

Type of Company

Private

Employees (Worldwide)

501 - 1,000

Industries

Computer Software
Hospitals & Patient Services
Medical Support Services
Other Business & Consulting Services
Internet Software & Services
Holding Companies
IT Consulting & Services

Company Description

XIFIN, Inc. engages as a healthcare information technology company. Its products and services include revenue cycle management, laboratory information systems, precision medicine informatics, and digital pathology consultation. The company was founded by Lâle White, Donald Lavigne, Michael Coats, and Jeffrey Yates in 1997 and is headquartered in San Diego, CA.

Contact Data
Trying to get in touch with decision makers at XIFIN, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder

Chief Technology Officer, Co-Founder

Executive Vice President & Chief Financial Officer

Chief Operating Officer

Senior Vice President, General Counsel & Chief Compliance Officer

Chief Marketing Officer

Chief Customer Officer

Chief Strategy Officer

Chief Architect & Vice President

Chief People Officer

Board of Directors

Founder at XIFIN, Inc.

Co-Founder at Avista Capital Partners

Operating Executive at Avista Capital Partners

Partner at Avista Capital Partners

Principal at Avista Capital Partners

Vice President at Avista Capital Partners

Paths to XIFIN, Inc.
Potential Connections via
Relationship Science
You
XIFIN, Inc.
Recent Transactions
Details Hidden

GTCR LLC purchases XIFIN, Inc.

Transaction Advisors
Legal Advisor

Advised onGTCR LLC purchases XIFIN, Inc.

Investment Advisor

Advised onGTCR LLC purchases XIFIN, Inc.

Legal Advisor

Advised onGTCR LLC purchases XIFIN, Inc.

Clients

iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers Zio XT, is a wearable patch-based biosensor, continuously records, and stores ECG data from every patient heartbeat for up to 14 consecutive days; and Zio AT, also provides ECG data but also provides physicians with actionable notifications during the wear period. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Investors
Details Hidden

Avista invests in middle market healthcare companies located in the US. The firm target companies in sectors such as pharmaceuticals, medical devices, outsourced pharmaceutical services, distribution, and consumer-driven healthcare. They provides financing for leveraged buyouts, build-ups, structured investments and growth capital requirements with an investment size ranging from USD50 to USD300 million per transaction. They consider both controlling and minority investments.

Details Hidden

Investor at PathCentral, Inc.

Details Hidden

Boulder Ventures focuses on equity investments in early-stage and emerging-growth technology companies, primarily in the information technology and life sciences sectors. About 75% of their investments are in information technology companies and about 25% of their investments are in life sciences companies. The firm invests in companies throughout the US.Within the information technology sector, Boulder Ventures focuses on the following areas: software, Internet-based business applications and services, information management and communications infrastructure and services. They look for companies with products that target large and fast-growing markets, improve quality, lower costs, speed up processes, increase productivity and provide a platform for new services. Boulder Ventures also looks for companies that expand the need to move and utilize information. In addition, they are particularly interested in service companies that use the Internet to streamline business-to-business activities.Within the life sciences sector, Boulder Ventures focuses on investments in life sciences tools, platforms, software, services and healthcare.Boulder Ventures generally serves as the lead investor in the deal in which they participate. Initial investments range from $1 million to $4 million. The firm typically invests from $5 million to $10 million over the life of a company. They also expect to provide follow-on capital in later rounds of equity financing. In addition, Boulder Ventures can arrange mezzanine financing, bank loans, leasing and other capital. They also represent and advise their portfolio companies throughout the exit process which may include a sale or IPO.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by XIFIN, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of XIFIN, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and XIFIN, Inc..